{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:14:15Z","timestamp":1792602855624,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.lfs.2021.119118","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T17:20:34Z","timestamp":1612372834000},"page":"119118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer"],"prefix":"10.1016","volume":"270","author":[{"given":"Negar","family":"Khoshghamat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajiheh","family":"Toloue-pouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakiba","family":"Azami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyedeh Helya","family":"Mirnourbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Rajabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2021.119118_bb0005","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology."},{"issue":"10073","key":"10.1016\/j.lfs.2021.119118_bb0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial","volume":"389","author":"Neoptolemos","year":"2017","journal-title":"Lancet"},{"issue":"44","key":"10.1016\/j.lfs.2021.119118_bb0015","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119118_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692231","article-title":"Current and future biomarkers for pancreatic adenocarcinoma","volume":"39","author":"Loosen","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2021.119118_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jbior.2014.05.001","article-title":"Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment","volume":"56","author":"Fitzgerald","year":"2014","journal-title":"Adv Biol Regul."},{"key":"10.1016\/j.lfs.2021.119118_bb0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jtbi.2016.06.021","article-title":"A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy","volume":"406","author":"Li","year":"2016","journal-title":"J. Theor. Biol."},{"issue":"28","key":"10.1016\/j.lfs.2021.119118_bb0035","doi-asserted-by":"crossref","first-page":"8678","DOI":"10.3748\/wjg.v21.i28.8678","article-title":"Screening for pancreatic cancer in familial high-risk individuals: a systematic review","volume":"21","author":"Lu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.119118_bb0040","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2147\/DDDT.S60328","article-title":"Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies","volume":"9","author":"Chiorean","year":"2015","journal-title":"Drug Des Devel Ther."},{"issue":"3","key":"10.1016\/j.lfs.2021.119118_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1753944716644130","article-title":"Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering","volume":"10","author":"Dusing","year":"2016","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0050","first-page":"409","article-title":"Angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis prevents pancreatic acinar cell inflammatory response via inhibition of the p38 mitogen-activated protein kinase\/nuclear factor-kappaB pathway","volume":"41","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"19","key":"10.1016\/j.lfs.2021.119118_bb0055","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1158\/1078-0432.CCR-17-0256","article-title":"Use of angiotensin system inhibitors is associated with immune activation and longer survival in nonmetastatic pancreatic ductal adenocarcinoma","volume":"23","author":"Liu","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00432-014-1873-2","article-title":"The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients","volume":"141","author":"Nakai","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2021.119118_bb0065","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/carcin\/bgn171","article-title":"The renin\u2013angiotensin system and malignancy","volume":"29","author":"Ager","year":"2008","journal-title":"Carcinogenesis."},{"issue":"3","key":"10.1016\/j.lfs.2021.119118_bb0070","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.3892\/mmr.2017.6982","article-title":"Angiotensin-(1-7) attenuates caerulein-induced pancreatic acinar cell apoptosis","volume":"16","author":"Cui","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2021.119118_bb0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2036.2011.04810.x","article-title":"Pancreatic renin\u2013angiotensin systems in health and disease","volume":"34","author":"Skipworth","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2021.119118_bb0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000337979","article-title":"How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?","volume":"83","author":"Kim","year":"2012","journal-title":"Oncology."},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/bjc.2016.375","article-title":"The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer","volume":"116","author":"Mandilaras","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2021.119118_bb0090","doi-asserted-by":"crossref","unstructured":"Pereira LX, Alves da Silva LC, de Oliveira Feitosa A, Santos Ferreira RJ, Fernandes Duarte AK, da Conceicao V, et al. Correlation between renin-angiotensin system (RAS) related genes, type 2 diabetes, and cancer: Insights from metanalysis of transcriptomics data. Mol Cell Endocrinol. 2019;493:110455.","DOI":"10.1016\/j.mce.2019.110455"},{"issue":"7","key":"10.1016\/j.lfs.2021.119118_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019075","article-title":"The renin-angiotensin system blockers and survival in digestive system malignancies: a systematic review and meta-analysis","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.lfs.2021.119118_bb0100","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0105","first-page":"H958","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.lfs.2021.119118_bb0110","doi-asserted-by":"crossref","unstructured":"T Lau S, S Leung P. Role of the RAS in pancreatic cancer. Curr. Cancer Drug Targets 2011;11(4):412\u201320.","DOI":"10.2174\/156800911795538110"},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11605-007-0403-9","article-title":"Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1\/2 signaling","volume":"12","author":"Anandanadesan","year":"2008","journal-title":"J. Gastrointest. Surg."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0120","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jamcollsurg.2007.01.067","article-title":"Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma","volume":"204","author":"Arafat","year":"2007","journal-title":"J. Am. Coll. Surg."},{"issue":"2","key":"10.1016\/j.lfs.2021.119118_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1443-9573.2004.00158.x","article-title":"Angiotensin II type 1 receptor mRNA and its protein expression in human pancreatic cancer cell lines","volume":"5","author":"Jiang","year":"2004","journal-title":"Chin. J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/CEJ.0000000000000269","article-title":"The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis","volume":"26","author":"Song","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2021.119118_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bcp.2018.03.008","article-title":"The role of angiotensin II in cancer metastasis: potential of renin-angiotensin system blockade as a treatment for cancer metastasis","volume":"151","author":"Ishikane","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119118_bb0140","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.pop.2014.08.002","article-title":"Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors","volume":"41","author":"Mercier","year":"2014","journal-title":"Prim. Care"},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0145","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119118_bb0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/156800911795538110","article-title":"Role of the RAS in pancreatic cancer","volume":"11","author":"Lau","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11605-007-0403-9","article-title":"Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1\/2 signaling","volume":"12","author":"Anandanadesan","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.lfs.2021.119118_bb0160","doi-asserted-by":"crossref","unstructured":"Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. Journal of the American College of Surgeons. 2007;204(5):996\u20131005; discussion-6.","DOI":"10.1016\/j.jamcollsurg.2007.01.067"},{"issue":"2","key":"10.1016\/j.lfs.2021.119118_bb0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1443-9573.2004.00158.x","article-title":"Angiotensin II type 1 receptor mRNA and its protein expression in human pancreatic cancer cell lines","volume":"5","author":"Jiang","year":"2004","journal-title":"Chin. J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/CEJ.0000000000000269","article-title":"The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis","volume":"26","author":"Song","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2021.119118_bb0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bcp.2018.03.008","article-title":"The role of angiotensin II in cancer metastasis: potential of renin-angiotensin system blockade as a treatment for cancer metastasis","volume":"151","author":"Ishikane","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119118_bb0180","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8188","article-title":"Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension","volume":"7","author":"Wei","year":"2019","journal-title":"PeerJ."},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-018-2789-5","article-title":"Renin angiotensin system and its role in biomarkers and treatment in gliomas","volume":"138","author":"Perdomo-Pantoja","year":"2018","journal-title":"J. Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119118_bb0190","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2165\/00003495-199549040-00003","article-title":"Choosing the right ACE inhibitor. A guide to selection","volume":"49","author":"Leonetti","year":"1995","journal-title":"Drugs."},{"key":"10.1016\/j.lfs.2021.119118_bb0195","doi-asserted-by":"crossref","unstructured":"Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. J Am Coll Surg. 2007;204(5):996\u20131005; discussion-6.","DOI":"10.1016\/j.jamcollsurg.2007.01.067"},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0200","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/gut.2009.188961","article-title":"The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer","volume":"59","author":"Fendrich","year":"2010","journal-title":"Gut."},{"issue":"3","key":"10.1016\/j.lfs.2021.119118_bb0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00002512-200016030-00006","article-title":"Losartan: a review of its use, with special focus on elderly patients","volume":"16","author":"Simpson","year":"2000","journal-title":"Drugs Aging"},{"issue":"9","key":"10.1016\/j.lfs.2021.119118_bb0210","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1054\/bjoc.2001.2102","article-title":"AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma","volume":"85","author":"Rivera","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.lfs.2021.119118_bb0215","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.119118_bb0220","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0225","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0230","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/gut.2009.188961","article-title":"The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer","volume":"59","author":"Fendrich","year":"2010","journal-title":"Gut."},{"issue":"11","key":"10.1016\/j.lfs.2021.119118_bb0235","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/0008-5472.CAN-14-3511","article-title":"TGF\u03b2 is a master regulator of radiation therapy-induced antitumor immunity","volume":"75","author":"Vanpouille-Box","year":"2015","journal-title":"Cancer Res."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2021.119118_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000101300","article-title":"Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells","volume":"185","author":"Bates","year":"2007","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.lfs.2021.119118_bb0245","doi-asserted-by":"crossref","unstructured":"T Sankpal U, Maliakal P, Bose D, Kayaleh O, Buchholz D, Basha R. Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy. Curr. Med. Chem. 2012;19(22):3779\u201386.","DOI":"10.2174\/092986712801661077"},{"issue":"8","key":"10.1016\/j.lfs.2021.119118_bb0250","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2036.2011.04810.x","article-title":"Review article: pancreatic renin-angiotensin systems in health and disease","volume":"34","author":"Skipworth","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2021.119118_bb0255","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0260","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5114\/aoms.2018.74026","article-title":"Renin-angiotensin system inhibitor attenuates oxidative stress induced human coronary artery endothelial cell dysfunction via the PI3K\/AKT\/mTOR pathway","volume":"15","author":"Shi","year":"2019","journal-title":"Arch. Med. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2021.119118_bb0265","first-page":"783","article-title":"Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K\/Akt and MAPK signaling pathways","volume":"27","author":"Ni","year":"2012","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.lfs.2021.119118_bb0270","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/carcin\/bgh236","article-title":"Inhibition of human lung cancer cell growth by angiotensin-(1-7)","volume":"25","author":"Gallagher","year":"2004","journal-title":"Carcinogenesis."},{"issue":"12","key":"10.1016\/j.lfs.2021.119118_bb0275","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00109-018-1704-z","article-title":"Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K\/Akt\/mTOR signaling in human nasopharyngeal carcinoma xenografts","volume":"96","author":"Lin","year":"2018","journal-title":"J Mol Med (Berl)."},{"issue":"1","key":"10.1016\/j.lfs.2021.119118_bb0280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/CEJ.0000000000000269","article-title":"The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis","volume":"26","author":"Song","year":"2017","journal-title":"European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP)."},{"issue":"2","key":"10.1016\/j.lfs.2021.119118_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10552-011-9881-x","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review","volume":"23","author":"Mc Menamin","year":"2012","journal-title":"Cancer Causes & Control: CCC."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0290","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tranon.2016.07.004","article-title":"Noninvasive assessment of losartan-induced increase in functional microvasculature and drug delivery in pancreatic ductal adenocarcinoma","volume":"9","author":"Kumar","year":"2016","journal-title":"Transl. Oncol."},{"issue":"11","key":"10.1016\/j.lfs.2021.119118_bb0295","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6605955","article-title":"Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine","volume":"103","author":"Nakai","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.lfs.2021.119118_bb0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/jcm7080197","article-title":"Anti-hypertensive medication use, soluble receptor for glycation end products and risk of pancreatic cancer in the Women\u2019s Health Initiative Study","volume":"7","author":"Wang","year":"2018","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.lfs.2021.119118_bb0305","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000492224","article-title":"Chemoprevention with enalapril and aspirin in Men1(+\/T) knockout mouse model","volume":"107","author":"Manoharan","year":"2018","journal-title":"Neuroendocrinology."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0310","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/ERC-14-0175","article-title":"Enalapril and ASS inhibit tumor growth in a transgenic mouse model of islet cell tumors","volume":"21","author":"Fendrich","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2021.119118_bb0315","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/gut.35.4.552","article-title":"Progression of alcoholic acute to chronic pancreatitis","volume":"35","author":"Ammann","year":"1994","journal-title":"Gut."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2021.119118_bb0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000323478","article-title":"Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis","volume":"11","author":"Sakurai","year":"2011","journal-title":"Pancreatology: Official Journal of the International Association of Pancreatology (IAP) [et al]."},{"issue":"9","key":"10.1016\/j.lfs.2021.119118_bb0325","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ene.12746","article-title":"Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma","volume":"22","author":"Januel","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"12","key":"10.1016\/j.lfs.2021.119118_bb0330","doi-asserted-by":"crossref","first-page":"18640","DOI":"10.18632\/oncotarget.15553","article-title":"The angiotensin receptor blocker, losartan, inhibits mammary tumor development and progression to invasive carcinoma","volume":"8","author":"Coulson","year":"2017","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.lfs.2021.119118_bb0335","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.18632\/oncotarget.6837","article-title":"Is angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers therapy protective against prostate cancer?","volume":"7","author":"Mao","year":"2016","journal-title":"Oncotarget."},{"issue":"4","key":"10.1016\/j.lfs.2021.119118_bb0340","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1746.2006.04797.x","article-title":"Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases","volume":"22","author":"Neo","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.lfs.2021.119118_bb0345","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/cbt.25092","article-title":"The renin angiotensin system regulates Kupffer cells in colorectal liver metastases","volume":"14","author":"Wen","year":"2013","journal-title":"Cancer Biol Ther."},{"issue":"5","key":"10.1016\/j.lfs.2021.119118_bb0350","first-page":"5059","article-title":"Renin angiotensin system deregulation as renal cancer risk factor","volume":"14","author":"Sobczuk","year":"2017","journal-title":"Oncol. Lett."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052100103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:47:39Z","timestamp":1758401259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052100103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":70,"alternative-id":["S002432052100103X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119118","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119118"}}